Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
Patents for C07D 493 - Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system (17,376)
11/2000
11/30/2000WO2000071544A1 Chromene compounds
11/30/2000WO2000071115A1 Antihypertensive compound from caesalpinia brasiliensis
11/30/2000CA2375072A1 Prodrug activation using catalytic antibodies
11/29/2000EP1054994A2 Fermentative preparation process for cytostatics and crystal forms thereof
11/29/2000EP1054663A1 Topiramate and related derivatives for treating schizophrenia
11/29/2000EP0863905B1 imidazole lipoxygenase inhibitors
11/28/2000US6153645 Heterocycles as antimicrobial agents
11/28/2000US6153627 For relaxing smooth muscle organs, blood circulation in coronary systems
11/28/2000US6153126 For ophthalmic plastic lenses
11/23/2000WO2000031081A3 Amino- and mercurio-substituted 4',5'-dihydropsoralens and therapeutical uses thereof
11/23/2000WO2000023059A3 Use of anticonvulsant derivatives for treating alcohol dependency
11/23/2000WO1999048482A3 Smilagenin and anzurogenin-d for the treatment of alzheimer's disease
11/22/2000EP1054010A1 Chromene compound
11/22/2000EP1054007A2 Method for the preparation of (+/-)-calanolide A
11/22/2000EP1053472A1 Energy transfer dyes
11/22/2000EP1052974A2 Compositions containing organic compounds
11/22/2000CN1274353A Halogen substituted tetracyclic tetrahydrofuran derivatives
11/22/2000CN1273972A Process for extracting raw rotenone
11/21/2000US6150539 Triptolide prodrugs having high aqueous solubility
11/21/2000US6150414 Inhibiting a virus causing infection (such as hiv) by administering the compound 1,3,4,6-tetrahydroxy-7,16-dioxo-7,16-dihydro-dibenzo(a,o)perylene
11/21/2000US6150402 Natriuretic compounds
11/21/2000US6150356 Potassium channel inhibitors and method
11/21/2000US6150069 Oxabicyclo compound, a polymer-containing said compound, and a photoresist micro pattern forming method using the same
11/21/2000US6150042 Material for organoelectro-luminescence device and use thereof
11/21/2000US6149841 Photochromic benzopyrano-fused naphthopyrans
11/21/2000CA2037608C Process for the preparation of castanospermine
11/16/2000WO2000006525A3 Synthesis of combinatorial libraries of compounds reminiscent of natural products
11/16/2000DE19923001A1 New epothilone derivatives, used as mitosis regulators e.g. for treating malignant tumors, psoriasis or arthritis
11/15/2000EP1051170A1 Application of substituted aminomethyl chromans in order to prevent neural degeneration and to promote neural regeneration
11/15/2000CN1273584A Imidazolyl-cyclic acetals
11/14/2000US6147230 Amino acid dysiherbaine
11/14/2000US6147110 Heterocyclic compounds
11/09/2000WO2000066599A1 Antioxidative vitamin b6 analogs
11/09/2000WO2000066589A1 6-alkenyl-, 6-alkinyl- and 6-epoxy-epothilone derivatives, process for their production, and their use in pharmaceutical preparations
11/09/2000WO2000066587A2 Polyamines and their use in therapy
11/09/2000WO2000066577A2 Brigded cycloalkanes as thromboxane ligands without blood clotting effects
11/09/2000WO2000066528A2 Quinones for treatment of diseases
11/09/2000WO2000066175A2 Conjugates as therapies for cancer and prostate diseases
11/09/2000WO2000039276A3 Microbial transformation method for the preparation of an epothilone
11/09/2000CA2372611A1 Quinones for treatment of diseases
11/09/2000CA2371653A1 Antioxidative vitamin b6 analogs
11/09/2000CA2368801A1 Conjugates as therapies for cancer and prostate diseases
11/08/2000EP1049796A1 Methods for the simultaneous identification of novel biological targets and lead structures for drug development
11/08/2000EP1049675A1 Chemokine receptor antagonists and methods of use therefor
11/08/2000EP1049537A2 Catalytic compositions and methods for asymmetric allylic alkylation
11/07/2000US6143905 1,7-diaroxy- or 1,7-arylthio-substituted perylene-3,4,9,10-tetracarboxylic acids, their dianhydrides and diimides
11/07/2000US6143904 Color former mixture
11/07/2000US6143725 For treating vascular diseases
11/07/2000US6143492 Compound useful as an optical probe; drug screening
11/07/2000US6143490 In vitro method for deactivation of viral, bacterial, or protozoan pathogen by adding compound consisting of intercalator nucleic acid binding ligand and an attached mustard group, treating the mixture, and recovering blood
11/02/2000WO2000064903A2 Methods for preparing antiviral calanolide compounds
11/02/2000WO2000064902A2 Process for the preparation of calanolide precursors
11/02/2000WO2000064842A1 Singlet oxygen oxidation of organic substrates
11/02/2000EP1047686A1 Substituted bicyclic lactones
11/02/2000EP1047685A1 Substituted beta,gamma-anellated lactones
11/02/2000EP1047675A1 Chemokine receptor antagonists and methods of use therefor
11/02/2000EP0713489B1 Photochromic heterocyclochromenes
11/02/2000DE19921086A1 New stable 6-alkenyl- or 6-alkynyl-epothilone derivatives, are cell division regulators useful for treating malignant tumors, angiogenesis or chronic inflammatory disease
11/01/2000CN1058011C 13-substituted milbemycin derivatives, and their use
10/2000
10/31/2000US6140513 Color forming dye precursor, composition containing the same and color forming heat-sensitive recording material
10/31/2000US6140358 Substituted phenyl keto enols as pesticides and herbicides
10/31/2000US6140273 Herbicides; made by reacting a cyclohexane-1,3-dione with an activated benzoic acid or benzoic acid compound, to give an acylation product, and subsequent rearrangement
10/31/2000US6140272 Substituted 4-benzoyl-pyrazoles
10/31/2000US6139781 Chemiluminescent electron-rich aryl-substituted 1,2-dioxetanes
10/31/2000CA2096345C Avermectins and milbemycins to treat parasitic in dogs
10/26/2000WO2000063212A1 Derivatives of triptolide, and preparation and uses thereof
10/26/2000WO2000035865A3 Tubulin-binding agents
10/25/2000EP1045912A1 Polyketides and their synthesis
10/25/2000EP1045841A1 Novel genipin derivative having liver protection activity
10/25/2000EP1045689A1 Synthesis of phenstatin and prodrugs thereof
10/24/2000US6136981 Preparation of 4-phenyl-1,2,3,6-tetrahydropyridines
10/24/2000US6136961 Biocatalytic methods for synthesizing and identifying biologically active compounds
10/24/2000US6136847 Water-soluble trioxanes as potent and safe antimalarial agents
10/24/2000US6136825 Sulfonamide compounds having 5-HT receptor activity
10/24/2000US6136800 Steroids
10/24/2000CA2157247C Physical form of dihydro-2,3-benzodiazepine derivative
10/19/2000WO2000061571A1 4,5-diaryl-3(2h)-furanone derivatives as cyclooxygenase-2 inhibitors
10/19/2000WO2000061524A1 Singlet oxygen oxidation of organic substrates
10/19/2000WO2000061139A1 Anticonvulsant derivatives useful in reducing blood glucose levels
10/19/2000WO2000061138A1 Anticonvulsant derivatives useful in treating chronic neurodegenerative disorders
10/19/2000WO2000061137A1 Anticonvulsant derivatives useful in lowering lipids
10/19/2000DE19908767A1 New stable, modified epothilone derivatives, are cell division regulators useful for treating malignant tumors, angiogenesis or chronic inflammatory disease
10/18/2000EP1044066A1 Batch devices for the reduction of compounds from biological compositions containing cells and methods of use
10/18/2000EP1043988A1 C-10 carbon-substituted artemisinin-like trioxane compounds having antimalarial, antiproliferative and antitumour activities
10/18/2000EP0773965B1 Gas phase production of polydienes
10/18/2000CN1270589A Epothilone derivatives
10/18/2000CN1270519A Anti-first-pass effect compounds
10/17/2000US6133460 Have primary amino substitutions on the 3-, 4-, 5-, and 8-positions of the psoralen which permit binding to nucleic acid of pathogens; conditions that photoactivate these psoralens result in inactivation of pathogens which contain nucleic acid
10/17/2000US6133459 Method and compositions providing enhanced chemiluminescence from 1,2-dioxetanes
10/17/2000US6133445 Rigidized trimethine cyanine dyes
10/17/2000US6133311 Method for preventing or treating elevated blood lipid level-related diseases by administering natural phenolic compounds
10/17/2000US6133296 Substituted pyridyl keto enols
10/17/2000US6133288 2,8-di(hydroxy)-5-((2-piperidin-1-yl)ethyoxy-1,4-phenylene)-)-5h -benzo-(e)naphtho(1,2-c)pyran; post-menopausal syndrome, osteoporosis, cardiovascular disorders; uterine fibrosis, endometriosis, and aortal smooth muscle cell proliferation
10/12/2000WO2000059501A1 Water-soluble trioxanes as potent and safe antimalarial agents
10/11/2000EP1043326A1 Steroid receptor modulator compounds and methods
10/11/2000EP1043325A1 Steroid receptor modulator compounds and methods
10/11/2000EP1043315A1 Steroid receptor modulator compounds and methods
10/11/2000EP1042328A1 Sarcodictyin and eleutherobin derivatives useful for stabilising microtubles
10/11/2000EP1042319A1 Dihydrobenzofurans
10/10/2000US6130349 Catalytic compositions and methods for asymmetric allylic alkylation
1 ... 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 ... 174